New Biological Therapies for Asthma: Do the Benefits Justify the Cost?

PDF Moderators:

• John Oppenheimer, FACAAI, MD, Director of Clinical Research, Pulmonary and Allergy Associates and Clinical Professor of Medicine, Rutgers University

Panelists:

• Aruni S. Arachchige Don, PhD, Consultant, Defined Health
• Ed Saltzman, President, Defined Health